This New Jersey bill requires hospitals providing breast cancer surgical treatments (like mastectomy or lumpectomy) to give patients written notice at diagnosis - before surgery consent - about their rights to consult with any board-certified plastic surgeon (regardless of hospital or insurance network) and coverage for reconstructive surgery under state/federal law. It also prohibits health insurance contracts from blocking doctors from recommending plastic surgeons outside their network or denying reconstructive surgery coverage based solely on a surgeon’s network status. The policy applies specifically to patients undergoing treatment for breast cancer, breast cancer genes, or other breast abnormalities. Hospitals must provide this notice upon diagnosis, ensuring patients understand their options for reconstruction and coverage.
This bill (A 3432) requires health insurance plans in New Jersey (both hospital and medical service corporation contracts) to cover specific preventive services without cost-sharing. It mandates coverage for USPSTF "A"/"B" rated services, CDC-recommended immunizations, pediatric care guidelines, and women's preventive services, with coverage required at least once per calendar year (not policy year). Plans must cover out-of-network services when no in-network provider is available for covered services, and coverage begins one year after a new recommendation is issued. The bill affects all applicable insurance contracts issued or renewed in New Jersey, ensuring broader access to preventive care without patient cost-sharing for these specific services. (Note: The bill was withdrawn after being approved as P.L.2025, c.386.)
This bill requires all health insurance plans in New Jersey that cover prostheses to include coverage for hair headpieces (human or artificial) worn to conceal scalp hair loss caused by chemotherapy for cancer patients. It applies to hospital service corporations, medical service corporations, health service corporations, individual policies, group policies, and health benefits plans. Coverage is mandatory only when a treating physician provides a written recommendation that the headpiece is medically necessary, and it must follow the same limitations as other prostheses under the plan. The law affects cancer patients undergoing chemotherapy who rely on insurance for these headpieces, ensuring they are covered under existing prosthetic coverage rules.
This New Jersey bill (A2483) requires health insurance plans to cover scalp cooling systems used during cancer chemotherapy to prevent hair loss. It applies to all major insurance types in the state - hospital service contracts, medical service contracts, individual policies, group plans, and health benefits plans - that already cover chemotherapy. Insurers must provide this coverage "to the same extent as for any other condition" under the policy, without additional patient cost. The bill directly affects cancer patients receiving chemotherapy who may use scalp cooling devices, ensuring these treatments are covered as part of standard medical benefits.
This bill establishes a 19-member Task Force on Institutional Discrimination in Health Care within New Jersey's Department of Health. The task force will study why health outcomes differ for patients of different races and socioeconomic backgrounds, reviewing existing research and identifying specific policies to reduce these disparities - including hospital analyses and anti-racism training for medical professionals. It requires the task force to submit a report to the Governor and Legislature within six months, after which the task force will expire. The bill directly affects New Jersey's health care system by mandating a formal review of systemic inequities, without creating new laws or regulations.
This New Jersey bill (A2287) requires health insurance plans covering groups of 50+ people to include coverage for fertility preservation services when medical treatments (like cancer therapy) may cause infertility. It specifically adds storage of sperm or oocytes to existing coverage, but excludes individuals under 21 years old. Insurers must cover these services under the same terms as other medical treatments and cannot deny coverage based on personal characteristics like age, gender, or health conditions. The bill applies to hospital, medical, and health service corporation contracts approved in New Jersey.
This New Jersey bill (A2116) requires all health insurance plans sold in the state - covering hospital, medical, and group policies - to include coverage for Alzheimer's disease and related dementia screening for people aged 65 or older. It mandates that this coverage be provided "to the same extent as for any other condition" under the plan, meaning no extra costs or restrictions beyond standard medical coverage. The law applies to all insurance types (including HMOs and health benefits plans) delivered, issued, or renewed in New Jersey after the bill's effective date. It defines "Alzheimer's disease and related disorders" as dementia causing significant impairment in daily functioning. The bill does not create new costs for insurers but ensures existing coverage must include these screenings for seniors.
S3409 prohibits New Jersey hospitals from billing patients for facility fees when services are provided at outpatient facilities affiliated with the hospital. The bill defines "facility fee" as charges covering hospital operational costs (distinct from professional fees charged by doctors). This directly affects patients receiving outpatient care at hospital-affiliated clinics, preventing additional billing for facility costs. The law applies to all licensed general acute care hospitals in New Jersey and takes effect immediately.
This bill requires all basic life support ambulances and volunteer ambulance squad vehicles in New Jersey to carry epinephrine auto-injectors and be staffed by at least one emergency medical technician (EMT) certified to administer them. It directly affects ambulance services, including both paid and volunteer emergency response units, by mandating specific equipment and personnel standards for treating severe allergic reactions. The law defines "basic life support" as standard pre-hospital care and clarifies that the requirements do not override existing federal or state staffing regulations. The bill takes effect 180 days after enactment.
This bill authorizes paramedics and other advanced life support providers in New Jersey to administer blood products (like whole blood or packed red blood cells) during emergencies outside hospitals, under supervision by a trauma-trained physician. It requires providers to complete state-approved training, use FDA-approved equipment for storage and transport, and have two trained personnel present during transfusions. The law mandates that Medicaid and private insurers cover these pre-hospital blood transfusions at the same rate as hospital-based services, with the state creating grants to help EMS agencies cover initial equipment and training costs. It directly affects emergency medical services agencies, their certified providers, and patients experiencing severe bleeding from trauma or postpartum hemorrhage.
